Use of locally produced anti-CD19 CAR-T cells in the treatment of relapsed/refractory B-cell lymphomas in adults

Use of locally produced anti-CD19 CAR-T cells in the treatment of relapsed/refractory B-cell lymphomas in adults

Background. Patients with B-cell lymphoma have an extremely unfavorable prognosis after relapse or in case of refractoriness to the first and consecutive lines of immunochemotherapy with the anti-CD19 CAR-T cells being the only therapeutic option to such patients. the manual preparation of anti-CD19...

Full description

Saved in:
Bibliographic Details
Main Authors: N. E. Konoplya, O. A. Kalenik, I. N. Severin, A. A. Savritskaya, N. M. Bobrova, T. M. Doroshenko, A. S. Portyanko
Format: Article
Language:Russian
Published: ABV-press 2023-09-01
Series:Онкогематология
Subjects:
car-t therapy
cd-19
b-cell lymphoma
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/832
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items